| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 37875 | World Patent Information | 2014 | 11 Pages |
Abstract
Leveraging available technologies for high-throughput screening (HTS), to enable the rapid delivery of comprehensive data packages for drug discovery programs, is a primary goal in developing new molecular entities for clinical applications. Pharmaceutical companies like Bristol-Myers Squibb (BMS) must constantly evolve their assay methods to ensure an effective and timely impact to business. This article is focused on a novel three step approach, using Linguamatics I2E text analytics software to mine the full text of patents, to identify (1) kinase assay technology information, and (2) kinase group information that is associated with therapeutic areas for drug screening.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Yun Yun Yang, Thomas Klose, Jonathan Lippy, Cynthia S. Barcelon-Yang, Litao Zhang,